Friday - August 14, 2026
Goodwin Advises Zealand Pharma on Entering Into a $100 Million Royalty Purchase and Sale Agreement With Royalty Pharma for the Economics Related to rusfertide
August 13, 2026
BOSTON, Massachusetts, Aug. 13 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:

* * *

Goodwin Advises Zealand Pharma on Entering Into a $100 Million Royalty Purchase and Sale Agreement With Royalty Pharma for the Economics Related to rusfertide

*

The Life Sciences team advised Zealand Pharma A/S on entering into a royalty purchase and sale agreement with Royalty Pharma plc in exchange for Zealand Pharma's . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products